Lipid-based nano delivery of Tat-peptide conjugated drug or vaccine–promising therapeutic strategy for SARS-CoV-2 treatment

Emerging coronaviruses: Genome structure, replication, and pathogenesis

(2020) Yu Chen et al.   JOURNAL OF MEDICAL VIROLOGY

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Return of the Coronavirus: 2019-nCoV

(2020) Lisa E. Gralinski et al.   Viruses-Basel

The Middle East Respiratory Syndrome (MERS)

(2019) Esam I. Azhar et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma

(2018) Hongyun Zhao et al.   Theranostics

Cell penetrating peptides: A concise review with emphasis on biomedical applications

(2018) Hossein Derakhshankhah et al.   BIOMEDICINE & PHARMACOTHERAPY

Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy

(2018) Prem Prakash Tripathi et al.   Oncotarget

Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections

(2017) David Lembo et al.   Expert Opinion on Drug Delivery

MERS, SARS and other coronaviruses as causes of pneumonia

(2017) Yudong Yin et al.   RESPIROLOGY

Current applications of nanoparticles in infectious diseases

(2016) Hinojal Zazo et al.   JOURNAL OF CONTROLLED RELEASE

Cell penetration: scope and limitations by the application of cell-penetrating peptides

(2014) Siegmund Reissmann   JOURNAL OF PEPTIDE SCIENCE

Cell-Penetrating HIV1 TAT Peptides Can Generate Pores in Model Membranes

(2010) Corina Ciobanasu et al.   BIOPHYSICAL JOURNAL